Drug Monitoring

"Drug Monitoring" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.

Descriptor ID	D016903
MeSH Number(s)	E01.370.520.200
Concept/Terms	Drug Monitoring Drug Monitoring Monitoring, Drug Therapeutic Drug Monitoring Therapeutic Drug Monitoring Drug Monitoring, Therapeutic Monitoring, Therapeutic Drug

Below are MeSH descriptors whose meaning is more general than "Drug Monitoring".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Monitoring, Physiologic [E01.370.520]
Drug Monitoring [E01.370.520.200]

Below are MeSH descriptors whose meaning is related to "Drug Monitoring".

Below are MeSH descriptors whose meaning is more specific than "Drug Monitoring".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Monitoring" by people in this website by year, and whether "Drug Monitoring" was a major or minor topic of these publications.

Bar chart showing 134 publications over 27 distinct years, with a maximum of 12 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	0	1	1
1998	0	1	1
1999	0	2	2
2000	0	1	1
2002	0	2	2
2003	1	2	3
2004	1	2	3
2005	2	0	2
2006	0	4	4
2007	2	2	4
2008	4	2	6
2009	2	3	5
2010	1	2	3
2011	1	4	5
2012	5	3	8
2013	5	2	7
2014	7	4	11
2015	5	4	9
2016	2	3	5
2017	7	4	11
2018	6	4	10
2019	6	6	12
2020	8	1	9
2021	4	1	5
2024	1	2	3
2025	0	1	1

Below are the most recent publications written about "Drug Monitoring" by people in Profiles.

La Via L, Marino A, Cuttone G, Nunnari G, Deana C, Tesauro M, Voza A, Planinsic R, Longhitano Y, Zanza C. Critical Care Pharmacology of Antiretroviral Therapy in Adults. Eur J Drug Metab Pharmacokinet. 2025 Mar; 50(2):105-118.

View in: PubMed
Bakre S, Chang HY, Doshi JA, Goedel WC, Saberi P, Chan PA, Nunn A, Dean LT. Clinician Specialty and HIV PrEP Prescription Reversals and Abandonments. JAMA Intern Med. 2024 10 01; 184(10):1204-1211.

View in: PubMed
Schmoyer CJ, Sun K, Zack J, Kumar P, Shivashankar R. Adverse Events and Compliance Among Inflammatory Bowel Disease Patients Treated With Home- vs Office-Based Biologic Infusions. Inflamm Bowel Dis. 2024 09 03; 30(9):1529-1535.

View in: PubMed
Arshed M, Mahmud A, Minhat HS, Lim PY, Zakar R. Effectiveness of a Multifaceted Mobile Health Intervention (Multi-Aid-Package) in Medication Adherence and Treatment Outcomes Among Patients With Hypertension in a Low- to Middle-Income Country: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2024 06 19; 12:e50248.

View in: PubMed
Jimbo M, Andrews JR, Ahmed ME, Dundar A, Karnes RJ, Bryce AH, Kendi AT, Kwon ED, Lowe VJ, Bold MS. Prognostic role of 11C-choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy. Prostate. 2022 01; 82(1):41-48.

View in: PubMed
Conti RM, Padula WV, Becker RV, Salamone S. The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemia. J Manag Care Spec Pharm. 2021 Aug; 27(8):1077-1085.

View in: PubMed
Esquenazi A, Francisco GE, Feng W, Baricich A, Gallien P, Fanning K, Zuzek A, Bandari DS, Wittenberg GF. Real-World Adherence to OnabotulinumtoxinA Treatment for Spasticity: Insights From the ASPIRE Study. Arch Phys Med Rehabil. 2021 11; 102(11):2172-2184.e6.

View in: PubMed
Millenaar D, Schumacher H, Brueckmann M, Eikelboom JW, Ezekowitz M, Slawik J, Ewen S, Ukena C, Wallentin L, Connolly S, Yusuf S, B?hm M. Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial). Am J Cardiol. 2021 06 15; 149:27-35.

View in: PubMed
Lee SD, Shivashankar R, Quirk D, Zhang H, Telliez JB, Andrews J, Marren A, Mukherjee A, Loftus EV. Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments. J Clin Gastroenterol. 2021 03 01; 55(3):195-206.

View in: PubMed
Tang O, Foti K, Miller ER, Appel LJ, Juraschek SP. Factors Associated With Physician Recommendation of Home Blood Pressure Monitoring and Blood Pressure in the US Population. Am J Hypertens. 2020 09 10; 33(9):852-859.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement